Skip to main content
Erschienen in: Head and Neck Pathology 3/2021

05.02.2021 | Original Paper

Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma

verfasst von: Renu Rathee, Anju Devi, Anjali Narwal, Mala Kamboj, Sunita Singh

Erschienen in: Head and Neck Pathology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

MUC1 and MUC4 are two transmembranous proteins, which have been seen to express aberrantly in various human neoplasms and advocated as independent prognostic markers. Till now no extensive studies have been carried out on combined expression of MUC1 and MUC4 in oral leukoplakia and Oral squamous cell carcinoma. This study is an endeavour to evaluate Immunohistochemical coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral squamous cell carcinoma and furthr establish them as prognostic markers. Immunohistochemical analysis of MUC1 and MUC4 was done on 24 cases of Oral squamous cell carcinoma, 24 cases of leukoplakia and 12 normal oral mucosal tissues. Chi square test and one way ANOVA test were employed for statistical analysis. Normal oral mucosa and leukoplakia group showed higher frequency of negative immunoexpression compared to oral squamous cell carcinoma group. Furthur in Oral squamous cell carcinoma group, higher frequency of double positive coexpression in well and moderately differentiated oral squamous cell carcinoma and single positive coexpression in poorly differentiated oral squamous cell carcinoma was obtained. A definite rise of immunoexpression of MUC1 and MUC4 was observed from normal oral mucosa to leukoplakia to oral squamous cell carcinoma indicative of their contribution as diagnostic and prognostic markers.
Literatur
1.
Zurück zum Zitat Gupta N, Gupta R, Acharya AK, Patthi B, Goud V, Reddy S, et al. Changing trends in oral cancer-a global scenario. Nepal J Epidemiol. 2016;6(4):613–9.CrossRef Gupta N, Gupta R, Acharya AK, Patthi B, Goud V, Reddy S, et al. Changing trends in oral cancer-a global scenario. Nepal J Epidemiol. 2016;6(4):613–9.CrossRef
2.
Zurück zum Zitat Kohli M, Shivam AK, Ahuja P, Dutta J. Mucin-4: a novel marker for oral cancer. J Oral MaxillofacPathol. 2019;23(1):49–53. Kohli M, Shivam AK, Ahuja P, Dutta J. Mucin-4: a novel marker for oral cancer. J Oral MaxillofacPathol. 2019;23(1):49–53.
3.
Zurück zum Zitat Kumar MH, Sanjai K, Kumarswamy J, Keshavaiah R, Papaiah L, Divya S. Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 2016;20(2):214–48.CrossRef Kumar MH, Sanjai K, Kumarswamy J, Keshavaiah R, Papaiah L, Divya S. Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral Maxillofac Pathol. 2016;20(2):214–48.CrossRef
4.
Zurück zum Zitat Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.CrossRef Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.CrossRef
5.
Zurück zum Zitat Mahfouz ME, Rodrigo JP, Takes RP, Elsheikh MN, Rinaldo A, Brakenhoff RH, et al. Current potential and limitations of molecular diagnostic methods in head and neck cancer. Eur Arch Otorhinolaryngol. 2010;267(6):851–60.CrossRef Mahfouz ME, Rodrigo JP, Takes RP, Elsheikh MN, Rinaldo A, Brakenhoff RH, et al. Current potential and limitations of molecular diagnostic methods in head and neck cancer. Eur Arch Otorhinolaryngol. 2010;267(6):851–60.CrossRef
6.
Zurück zum Zitat Ghazi N, Ghazi A, Shafiee S, Fayyazi M. Importance of depth of invasion in patients with oral squamous cell carcinoma: A review article. J Orofac Sci. 2018;10(1):3–6. Ghazi N, Ghazi A, Shafiee S, Fayyazi M. Importance of depth of invasion in patients with oral squamous cell carcinoma: A review article. J Orofac Sci. 2018;10(1):3–6.
7.
Zurück zum Zitat Troeltzsch M, Knösel T, Eichinger C, Probst F, Troeltzsch M, Woodlock T, et al. Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups? J Oral Maxillofac Surg. 2014;72(7):1291–300.CrossRef Troeltzsch M, Knösel T, Eichinger C, Probst F, Troeltzsch M, Woodlock T, et al. Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups? J Oral Maxillofac Surg. 2014;72(7):1291–300.CrossRef
8.
Zurück zum Zitat Thakur A, Tupkari JV, Joy T, Kende PP, Siwach P, Ahire MS. Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral MaxillofacPathol. 2018;22(2):210–5. Thakur A, Tupkari JV, Joy T, Kende PP, Siwach P, Ahire MS. Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. J Oral MaxillofacPathol. 2018;22(2):210–5.
9.
Zurück zum Zitat Nitta T, Sugihara K, Tsuyama S, Murata F. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis. Cancer. 2000;88(2):245–54.CrossRef Nitta T, Sugihara K, Tsuyama S, Murata F. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis. Cancer. 2000;88(2):245–54.CrossRef
10.
Zurück zum Zitat Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, et al. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol. 2015;20(2):298–307.CrossRef Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, et al. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol. 2015;20(2):298–307.CrossRef
11.
Zurück zum Zitat Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer. 2002;94(6):1770–6.CrossRef Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer. 2002;94(6):1770–6.CrossRef
12.
Zurück zum Zitat Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004;39(1):220–9.CrossRef Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004;39(1):220–9.CrossRef
13.
Zurück zum Zitat Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, et al. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One. 2012;7(11):e49251.CrossRef Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, et al. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One. 2012;7(11):e49251.CrossRef
14.
Zurück zum Zitat Shobita, et al. Immunohistochemical expression of MUC1 in different grades of oral squamous cell carcinoma. Asian Pac J Health Sci. 2018;5(2):165–9.CrossRef Shobita, et al. Immunohistochemical expression of MUC1 in different grades of oral squamous cell carcinoma. Asian Pac J Health Sci. 2018;5(2):165–9.CrossRef
15.
Zurück zum Zitat Narashiman S, Narasimhan M, Venkatraman G. Expression of mucin 4 in leukoplakia and oral squamous cell carcinoma: an immunohistochemical study. J Oral MaxillofacPathol. 2014;18(1):25–31. Narashiman S, Narasimhan M, Venkatraman G. Expression of mucin 4 in leukoplakia and oral squamous cell carcinoma: an immunohistochemical study. J Oral MaxillofacPathol. 2014;18(1):25–31.
16.
Zurück zum Zitat Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, et al. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer. 2012;130(8):1768–76.CrossRef Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, et al. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer. 2012;130(8):1768–76.CrossRef
17.
Zurück zum Zitat Abidullah M, Nahar P, Ahmed SA. Expression of MUC4 in Oral Dysplastic Epithelium. Int J Pharm Investigation. 2019;9(2):85–8.CrossRef Abidullah M, Nahar P, Ahmed SA. Expression of MUC4 in Oral Dysplastic Epithelium. Int J Pharm Investigation. 2019;9(2):85–8.CrossRef
18.
Zurück zum Zitat Nakamori S, et al. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology. 1994;106(2):353–61.CrossRef Nakamori S, et al. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology. 1994;106(2):353–61.CrossRef
19.
Zurück zum Zitat Tashiro Y, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Human Pathol. 1994;25(4):364–72.CrossRef Tashiro Y, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Human Pathol. 1994;25(4):364–72.CrossRef
20.
Zurück zum Zitat Osako M, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer. 1993;71(7):2191–9.CrossRef Osako M, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer. 1993;71(7):2191–9.CrossRef
21.
Zurück zum Zitat Yamashita K, et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer. 1993;55(1):82–91.CrossRef Yamashita K, et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer. 1993;55(1):82–91.CrossRef
22.
Zurück zum Zitat Saitou M, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005;58(8):845–52.CrossRef Saitou M, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005;58(8):845–52.CrossRef
23.
Zurück zum Zitat Tamada S, et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res. 2006;12(14):4257–64.CrossRef Tamada S, et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res. 2006;12(14):4257–64.CrossRef
24.
Zurück zum Zitat Tsutsumida H, et al. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer. 2007;55(2):195–203.CrossRef Tsutsumida H, et al. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer. 2007;55(2):195–203.CrossRef
25.
Zurück zum Zitat Zhang Ai-Min et al. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Biosci Rep, 2019;39(9) Zhang Ai-Min et al. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Biosci Rep, 2019;39(9)
Metadaten
Titel
Immunohistochemical Coexpression of MUC1 and MUC4 in Oral Leukoplakia and Oral Squamous Cell Carcinoma
verfasst von
Renu Rathee
Anju Devi
Anjali Narwal
Mala Kamboj
Sunita Singh
Publikationsdatum
05.02.2021
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2021
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01291-y

Weitere Artikel der Ausgabe 3/2021

Head and Neck Pathology 3/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …